ClearBridge Investments’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

ClearBridge Investments’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$67.1M	Buy	423,739 +6,720	+2%	+$908K	0.06%	283
2026 Q1	$53.3M	Buy	417,019 +21,028	+5%	+$2.63M	0.05%	298
2025 Q4	$48.3M	Buy	395,991 +35,483	+10%	+$4.07M	0.04%	324
2025 Q3	$36.1M	Sell	360,508 -375,771	-51%	-$33.8M	0.03%	373
2025 Q2	$61.1M	Sell	736,279 -78,494	-10%	-$6.26M	0.05%	287
2025 Q1	$66.1M	Buy	814,773 +243,109	+43%	+$21.7M	0.06%	276
2024 Q4	$51.5M	Buy	571,664 +97,401	+21%	+$9.44M	0.04%	316
2024 Q3	$46.9M	Buy	+474,263	New	+$46.6M	0.04%	336
2018 Q3	–	Sell	-6,385	Closed	-$608K	–	1165
2018 Q2	$608K	Hold	6,385	–	–	﹤0.01%	673
2018 Q1	$560K	Hold	6,385	–	–	﹤0.01%	673
2017 Q4	$542K	Hold	6,385	–	–	﹤0.01%	684
2017 Q3	$553K	Hold	6,385	–	–	﹤0.01%	679
2017 Q2	$493K	Hold	6,385	–	–	﹤0.01%	682
2017 Q1	$443K	Buy	6,385 +585	+10%	+$39.3K	﹤0.01%	723
2016 Q4	$343K	Buy	5,800 +2,500	+76%	+$154K	﹤0.01%	748
2016 Q3	$219K	Buy	+3,300	New	+$204K	﹤0.01%	765

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

ClearBridge Investments's XBI Position: Q2 2026 in Review

ClearBridge Investments increased its State Street SPDR S&P Biotech ETF (XBI) stake by 1.6% in Q2 2026, buying an estimated $908K and bringing the position to 423,739 shares worth $67.1M. The position accounts for 0.06% of the portfolio, ranked #283.

ClearBridge Investments first reported a position in XBI in Q3 2016 and has held it in 16 quarters since. 932 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

ClearBridge Investments held 423,739 shares of State Street SPDR S&P Biotech ETF worth $67.1M as of Q2 2026.
ClearBridge Investments bought 6,720 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $908K.
State Street SPDR S&P Biotech ETF made up 0.06% of ClearBridge Investments's portfolio in Q2 2026, its #283 holding.
ClearBridge Investments first reported a position in State Street SPDR S&P Biotech ETF in Q3 2016 and has held it in 16 quarters since.
932 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on ClearBridge Investments's 13F filing for Q2 2026, filed 13 Aug 2026.